Production (Stage)
MediWound Ltd.
MDWD
$20.33
-$0.53-2.54%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | 20.14M | 19.85M | 18.69M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 20.14M | 19.85M | 18.69M | |
| Cost of Revenue | -- | 17.47M | 16.49M | 15.11M | |
| Gross Profit | -- | 2.67M | 3.36M | 3.58M | |
| SG&A Expenses | -- | 11.31M | 11.40M | 11.61M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | 0.00 | 0.00 | 0.00 | |
| Total Operating Expenses | -- | 35.49M | 34.72M | 34.19M | |
| Operating Income | -- | -15.35M | -14.87M | -15.50M | |
| Income Before Tax | -- | -19.78M | -12.55M | -6.53M | |
| Income Tax Expenses | -- | 190.00K | 204.00K | 185.00K | |
| Earnings from Continuing Operations | -- | -19.97 | -12.75 | -6.72 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -19.97M | -12.75M | -6.72M | |
| EBIT | -- | -15.35M | -14.87M | -15.50M | |
| EBITDA | -- | -14.10M | -13.66M | -14.36M | |
| EPS Basic | -- | -2.16 | -1.38 | -0.77 | |
| Normalized Basic EPS | -- | -1.11 | -0.62 | -0.62 | |
| EPS Diluted | -- | -2.16 | -1.38 | -0.77 | |
| Normalized Diluted EPS | -- | -1.11 | -0.62 | -0.62 | |
| Average Basic Shares Outstanding | -- | 36.95M | 36.88M | 36.03M | |
| Average Diluted Shares Outstanding | -- | 36.95M | 36.88M | 36.03M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |